Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 ...

We’ve long known that politicians influence how ordinary Americans think about education issues. Voters “follow the leader” — ...

Coronavirus testing turnaround time has improved since the early months of the pandemic, according to a new report, but it still isn’t fast enough — and racial disparities in testing persist.

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

ABBOTT warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in Covid-19 testing demand, new US tariffs and the government’s foreign aid freeze.

Childhood vaccines lay the foundation for lifelong health, protecting against diseases like measles, mumps, rubella, and polio.

State Health Officer tells Board of Health he’s confident MSDH will move through federal funding challenges, noting the ...

Abbott Laboratories (NYSE:ABT) reported second-quarter earnings that modestly beat analyst forecasts, yet the company’s shares dropped 2.5% following the announcement. The healthcare leader posted ...

Welcome to our live blog tracking the latest news and developments from China. Stay updated with real-time insights into the ...

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...

While most people will clear the virus and get a negative antigen test result within 10 days, some people may keep testing positive for longer than that, experts tell TODAY.com. And if you keep ...